Search

Author/Creator Buggisch, P.

1. Acoustic radiation force impulse imaging for non‐invasive assessment of liver fibrosis in chronic hepatitis B. Issue 4 (31st July 2012)

Authors:
Friedrich‐Rust, M.; Buggisch, P.; de Knegt, R. J.; Dries, V.; Shi, Y.; Matschenz, K.; Schneider, M. D.; Herrmann, E.; Petersen, J.; Schulze, F.; Zeuzem, S.; Sarrazin, C.
Journal:
Journal of viral hepatitis
Issue:
Volume 20:Issue 4(2013)
Page Start:
240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV type. Issue 11 (26th June 2016)

Authors:
Fülöp, B.; Mihm, U.; Rohde, P.; Buggisch, P.; Schlosser, B.; Biermer, M.; Brodzinski, A.; Fischer, J.; Böhm, S.; van Bömmel, F.; Sarrazin, C.; Berg, T.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 11(2016)
Page Start:
866
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)

Authors:
Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W.
Other Names:
Tanno Hugo investigator.; Bessone Fernando investigator.; Terg Ruben investigator.; Frider Bernardo investigator.; Bertuzzi Romina investigator.; Desmond Paul investigator.; Zekry Amany investigator.; Weltman Martin investigator.; George Jacob investigator.; Crawford Darrell investigator.; Matthe...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 7(2015)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)

Authors:
Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 7(2015)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry. Issue 10 (25th May 2017)

Authors:
Welzel, T. M.; Hinrichsen, H.; Sarrazin, C.; Buggisch, P.; Baumgarten, A.; Christensen, S.; Berg, T.; Mauss, S.; Teuber, G.; Stein, K.; Deterding, K.; van Bömmel, F.; Heyne, R.; John, C.; Zimmermann, T.; Lutz, T.; Schott, E.; Hettinger, J.; Kleine, H.; König, B.
Journal:
Journal of viral hepatitis
Issue:
Volume 24:Issue 10(2017)
Page Start:
840
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗